Pupillary Response After Glaucoma Medication

NCT02522039 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Drug Effect (Glaucoma Drugs)

Interventions

DRUG: Latanoprost
DRUG: Timolol
DRUG: Dorzolamide

Sponsor

Glostrup University Hospital, Copenhagen